Johnna Perdrizet, MPH

Global Value and Evidence Director, Pneumococcal Vaccines
Pfizer Inc

Disclosure(s): Pfizer Inc: Employee, Stocks/Bonds

Johnna Perdrizet (MPH) is a global director of value and evidence for pneumococcal vaccines at Pfizer Inc. She holds a Master of Public Health in Epidemiology from the University of Toronto and a Bachelor of Science from McGill University. Her research focuses on the health, economic and social benefits of vaccines.

Poster(s):

• 576 - Burden of Pneumococcal Disease Due to Serotypes Covered by the 13-Valent and New Higher-Valent Pneumococcal Conjugate Vaccines in All Children and Children at Risk in the United States
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 586 - Systematic Literature Review of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) Effectiveness Against Invasive Pneumococcal Disease in Children Globally
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET